Drug giant F. Hoffman-La Roche asked the Federal Court Tuesday for an order barring the release of a generic version of its blockbuster cancer drug MabThera by a unit of Swiss rival Novartis, which it claims could lead to “tens of millions of dollars” in losses.
A bidding war erupted Tuesday among law firms angling to lead a $2 billion shareholder class action against AMP, with Maurice Blackburn announcing a “super deal” and Quinn Emanuel besting that with a funding arrangement to “shake up” the market.
A judge overseeing a defamation case brought by billionaire Meriton founder Harry Triguboff against Fairfax Media must decide whether an article about the property company that appeared in the Australian Financial Review can be reasonably said to be about Triguboff.
SNF has filed an appeal with the Federal Court after the Australian Patent Office shot down its challenge to a mining patent application by rival BASF.
The ACCC is considering a report by US-based Oracle into Google’s tracking of Australian Android phone users as part of the regulator’s broader inquiry into digital media.
A Victorian Supreme Court judge has recused himself from proceedings over costs in a construction dispute, after vowing to send transcripts of the case to the state’s legal watchdog.
Take-Two Interactive has won a temporary injunction blocking a gamer from making unauthorised changes to its popular Grand Theft Auto video game.
7-Eleven has lost its bid to use a confidential bulletin sent to class members via WhatsApp as defence evidence in an ongoing franchisee class action, with a judge rejecting the company’s claims the document was no longer shielded by legal professional privilege.
Telecom giant Optus has come up short in a Federal Court challenge to trademark registration for health services company Optum, with a judge saying the two company’s marks — despite the difference of just one letter — were distinct enough.
A full bench of the Federal Court has dismissed an appeal by drug giant GlaxoSmithKline in a patent infringement case it brought over planned generic versions of its sustained-release Panadol.